An interventional study of NeuroEyeCoach eye movement training and Usual Care in Stroke, sponsored by Glasgow Caledonian University. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-07.
Sponsored by Glasgow Caledonian University · Not applicable, Interventional, and Other
The goal of this study is to learn whether NeuroEyeCoach, a computer-based eye movement training programme, can help stroke survivors with visual field loss. The study will also assess whether a larger clinical trial is feasible. The main questions it aims to answer are:
Participants will:
8,255 studies on the registry are indexed under Stroke; 2,056 are open to participants now.
This study's planned enrollment of 60 is above the median of 49 across 6,024 interventional studies indexed under Stroke.
Browse Stroke studies →Glasgow Caledonian University is the lead sponsor of 46 studies on the registry; 3 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Usual post-stroke care, plus eye movement training (VISIOcoach)
Device: NeuroEyeCoach eye movement training · Other: Usual Care
Usual post-stroke care
Other: Usual Care
computer based eye movement training for visual field loss in stroke
Usual post-stroke care
Recruitment rate
Rate of recruitment to the trial
Time frame: through study completion, estimated at 15 months
Retention Rate
Rate of retention of participants in the study
Time frame: through study completion, estimated at 15 months
Screening and eligibility rate
Screening and eligibility rate
Time frame: Active screening period
Outcome measure completion rate
through study completion, estimated at 15 months
Time frame: over data collection period
intervention adherence
adherence to recommended training regime (duration)
Time frame: 6 weeks
Adverse events
any adverse eventa experienced
Time frame: up to 6 weeks
Support and computer provision needs
To what extent must technical equipment or assistance be given
Time frame: up to 6 weeks
NEI VFQ 25 (National Eye Institute Visual Function Questionnaire-25)
Patient-reported measure of vision-related functioning. Minimum value is 0, and maximum value is 100; higher scores mean a better outcome
Time frame: baseline, 6 weeks post randomisation, 6 months post randomisation
EQ-5D 5L
Generic health related quality of life Maximum value 1.0; better scores mean a better outcome
Time frame: baseline, 6 weeks post randomisation, 6 months post randomisation
IReST (International Reading Speed Test)
Reading test (words per minute)
Time frame: baseline, 6 weeks post randomisation, 6 months post randomisation
Melbourne Rapid Fields
visual field test
Time frame: baseline, 6 weeks post randomisation, 6 months post randomisation
Confidence after Stroke Measure
Validated questionnaire that explores self-confidence, positive attitude and social confidence Minimum score is 0 and the maximum score is 81; a higher score indicates better outcome Ref: Horne JC, Lincoln NB, Logan PA. Measurement of confidence: the development and psychometric evaluation of a stroke-specific, measure of confidence. Clin Rehabil. 2017 Nov;31(11):1529-1537. doi: 10.1177/0269215517705424. Epub 2017 May 3. PMID: 28466669; PMCID: PMC5652651.
Time frame: baseline, 6 weeks post randomisation, 6 months post randomisation
Warwick-Edinburgh Mental Wellbeing Scale
Mental wellbeing questionnaire Minimum raw score is 7 and the maximum raw score is 35; higher score means a better outcome
Time frame: baseline, 6 weeks post randomisation, 6 months post randomisation
health care resource use
health care resource use, covering general, stroke specific, and vision specific resources
Time frame: baseline, 6 weeks post randomisation, 6 months post randomisation
No study locations are listed for this record.
Plan to share: Undecided — We have not yet discussed and decided our IPD sharing position
No publications or documents are linked to this record.
This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Glasgow Caledonian University